logo
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us

Home » Edward B. Mulligan V Appointed to Plaintiffs’ Steering Committee for Tenofovir Drug Litigation

Edward B. Mulligan V Appointed to Plaintiffs’ Steering Committee for Tenofovir Drug Litigation

Cohen & Malad, LLP partner Edward (Ned) B. Mulligan V has been appointed to the Plaintiffs’ Steering Committee for the Judicial Council Coordination Proceeding for Gilead Tenofovir lawsuits. The coordinated proceedings are being presided over by the Honorable Andrew Y.S. Cheng in the California Superior Court for San Francisco County.

As a member of the Plaintiffs’ Steering Committee, Ned serves on a team of highly qualified lawyers from around the country that is managing the pre-trial litigation against Gilead. Ned has also been named Co-Chair of the Discovery committee and in that role will oversee the discovery process, including depositions of Gilead witnesses and the production of internal Gilead documents.

Tenofovir drugs manufactured by Gilead Sciences are sold by the brand names Truvada, Atripla, Stribild, Viread, and Complera. These drugs are prescribed to treat HIV, for pre-exposure prophylaxis (PrEP) to mitigate HIV risk, or to treat Hepatitis.

Patients who have taken these drugs have reported serious injuries including chronic kidney disease and renal failure as well as bone loss, softening of the bones, and severe fractures.

In these cases, plaintiffs allege that Gilead Sciences intentionally withheld virtually identical but far safer versions of these drugs for more than a decade so that it could profit off of the more dangerous drug before releasing the safer version.

Cohen & Malad, LLP attorneys have built a reputation as tough opponents in the courtroom and have a depth of experience in litigating claims for people who have been injured by dangerous drugs and medical devices. Contact us for a free case evaluation if you were prescribed tenofovir drugs manufactured by Gilead Sciences including Truvada, Atripla, Stribild, Viread, or Complera and suffered a serious injury.

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

University of Southern California Agrees to $852 Million Settlement in Sexual Abuse Lawsuit

More than 700 women who claim University of Southern California campus gynecologist Dr. George Tyndall sexually abused .. Read More

SEE ALL ALERTS

In the News

Natalie A. Lyons Joins Class Action Practice at Cohen & Malad, LLP Six Cohen & Malad, LLP Attorneys Named to 2021 Indiana Super Lawyers Rising Stars List Thirteen Cohen & Malad, LLP Attorneys Named to 2021 Indiana Super Lawyers List
READ OUR NEWS